Next Health Capital

Next Health Capital is a private equity vehicle managed by Turenne Capital Partenaires SA and domiciled in France, launched in 2025 and denominated in EUR. It is structured as an ELTIF under the ELTIF 2.0 framework and authorised domestically under the FPCI regime, combining the French fund contractual form with the European long-term vehicle label that allows distribution to retail investors within its home market. The fund pursues a buyout strategy and is classified Article 9 under SFDR, placing sustainable investment at the level of the fund's stated objective rather than as a secondary characteristic.

The vehicle is closed-ended, so capital is committed for the life of the fund and drawn against the manager's deal pipeline rather than subscribed and redeemed on a dealing calendar; investors should plan around the absence of an ongoing redemption facility and expect liquidity to arise from realisations and the end-of-life wind-down. Capital raised to date stands at against a stated fundraising ambition of , and portfolio exposure is allocated across markets as shown in , which reflects the manager's domestic-centred sourcing footprint.

Within Novantigo's coverage of 494 vehicles as of 31 Aug 2026, Next Health Capital is one of 163 private equity funds, one of 80 funds domiciled in France, and one of the narrower set of 32 funds that combine both, which is the most direct comparison group for size, structure and strategy benchmarking.